inōtiv Corporate Presentation June 2023
Transformational Internal Investments Drive
Organic Growth / Improved Animal Welfare
Capital Allocation
2018-2022: ~$78 million invested
~$65 million in additional aggregate annual revenue run rate capacity added
Infrastructure upgraded and expanded Evansville, IN and St. Louis, MO
June 2023 YTD: ~$21.3 million invested
Buildout of newly leased 48,000 sq foot Maryland facility to support biotherapeutics
and genetic toxicology growth (substantially completed by end of Q2 FY 2023)
Colorado facilities (Boulder and Ft. Collins) expanded by approximately 50% revenue
run rate capacity (substantially completed by end of FY 2023)
Trends
Future investments expected to be less than 5% of annual revenue (vs. 5-year
average of 14%)
Expect lower G&A spend, which totaled $84.6 million over the first three
quarters of FY 2023
11 |
Expanded Evansville Facility
New St. Louis Laboratories
CORPORATE PRESENTATION
MACS
Quant
inōtiv
analyze, answer. advance..View entire presentation